Original document(46 pages)  中文版
    The invention discloses a group of immunomodulatory agents, which can be used for the treatment of autoimmune diseases or organ transplantation through immunological inhibitory actions.
Application Number
申请号		 200610004604 Application Date
申请日		 2003.02.14
Title 名称 Immunity regulator and its application
Publication Number
公开号		 1840192 Publication Date
公开日		 2006.10.04
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K39/395,A61P37/00,A61P37/06,C12N15/62
Applicant(s) Name
申请人		 Ma Jing
Address 地址 201203
Inventor(s) Name 发明人
Attorney & Agent 代理人 xu xun
More information 更  多  信  息


 Related patents information
Recombinant gene of soluble part in tumor necrosis factor acceptor and its fusion gene and product
Humanized anti-HER 2 monoclonal antibody, its preparation method and pharmaceutical composition thereof
Monoclonal antibody of melanic related antigen, and its application and medicine composition
Humanmachine tumour monoclonal antibody, and its preparing method and use
Anti CD52 monoclonal antibody, coding sequence and use thereof
Embedded CD25-resisting monoclonal antibody and its coding sequence and application
Tumour necrosis factor antibody preparing method and medicinal composition thereof
Immunological regulator and application thereof
Recombinated anti-CD25 monoclonal antibody, coding sequence and application
Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.